US2002164742A1PendingUtilityA1
DNA encoding methymycin and pikromycin
Est. expiryJun 26, 2018(expired)· nominal 20-yr term from priority
C12P 19/62C12P 7/42C12N 15/52
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A novel pathway for the synthesis of polyhydroxyalkanoates is provided. A method of synthesizing a recombinant polyhydroxyalkanoate monomer synthase is also provided. These recombinant polyhydroxyalkanoate synthases are derived from multifunctional fatty acid synthases or polyketide synthases and generate hydroxyacyl acids capable of polymerization by a polyhydroxyalkanoate synthase. Also provided is a biosynthetic gene cluster for methymycin and pikomycin as well as a biosynthetic gene cluster for desosamine.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated and purified nucleic acid segment comprising a nucleic acid sequence comprising a desosamine biosynthetic gene cluster, a fragment or a biologically active variant thereof, wherein the nucleic acid sequence is not derived from the eryC gene cluster of Saccharopolyspora erythraea or Streptomyces antibioticus.
2 . The isolated and purified nucleic acid segment of claim 1 comprising SEQ ID NO:3.
3 . The isolated and purified nucleic acid segment of claim 1 which encodes DesI, DesII, DesIII, DesIV, DesV, DesVI, DesVII, DesVIII or DesR.
4 . The isolated and purified nucleic acid segment of claim 1 which is from Streptomyces venezuelae.
5 . An expression cassette comprising the nucleic acid segment of claim 1 operably linked to a promoter functional in a host cell.
6 . A recombinant bacterial host cell in which at least a portion of a nucleic acid sequence encoding desosamine is disrupted so as to result in a decrease or lack of desosamine synthesis, wherein the nucleic acid sequence which is disrupted is not derived from the eryC gene cluster of Saccharopolyspora erythraea.
7 . The host cell of claim 6 wherein the nucleic acid sequence which is disrupted encodes DesI, DesII, DesIII, DesIV, DesV, DesVI, DesVII, DesVIII or DesR.
8 . A host cell, the genome of which is augmented with the expression cassette of claim 5 .
9 . A product produced by the host cell of claim 6 which is not produced by the corresponding non-recombinant host cell.
10 . The product of claim 9 which comprises a macrolide.
11 . An isolated and purified nucleic acid segment comprising a nucleic acid sequence comprising a macrolide biosynthetic gene cluster encoding methymycin, pikomycin, neomethymycin, narbomycin, or a combination thereof, or a biologically active variant or fragment thereof.
12 . The isolated and purified nucleic acid segment of claim 11 comprising SEQ ID NO:5.
13 . The isolated and purified nucleic acid segment of claim 11 comprising a biologically active variant or fragment of SEQ ID NO:5.
14 . The isolated and purified nucleic acid segment of claim 11 which encodes PikR1, PikR2, PikAI, PikAII, PikAIII, PikAIV, PikAV, PikC or PikD.
15 . The isolated and purified nucleic acid segment of claim 11 which is from Streptomyces venezuelae.
16 . A host cell, the genome of which is augmented with the nucleic acid segment of claim 11 .
17 . An isolated and purified nucleic acid sequence comprising SEQ ID NO:3, SEQ ID NO:5, a fragment thereof, the complement thereto, or which hybridizes thereto.
18 . An isolated polypeptide encoded by the nucleic acid segment of claim 1 or 11 .
19 . A recombinant host cell in which a pikAI gene, a pikAII gene, a pikAIII gene, a pikAIV gene, a pikB gene cluster, a pikAV gene cluster, a pikC gene, a pikR1 gene, apikR2 gene, or a combination thereof, is disrupted so as to reduce or eliminate production of methymycin, neomethymycin, pikromycin, narbomycin, or a combination thereof.
20 . A macrolide or polyketide produced by the host cell of claim 19 which is not produced by the corresponding non-recombinant host cell.
21 . An isolated and purified DNA molecule comprising a first DNA segment encoding a first module and a second DNA segment encoding a second module, wherein the DNA segments together encode a recombinant polyhydroxyalkanoate monomer synthase, and wherein at least one DNA segment is derived from the pikA gene cluster of Streptomyces venezuelae.
22 . A method of providing a polyhydroxyalkanoate monomer, comprising:
(a) introducing into a host cell a DNA molecule comprising a DNA segment encoding a recombinant polyhydroxyalkanoate monomer synthase operably linked to a promoter functional in the host cell, wherein the recombinant polyhydroxyalkanoate monomer synthase comprises a first module and a second module, and wherein at least one DNA segment is derived from the pikA gene cluster of Streptomyces venezuelae ; and (b) expressing the DNA encoding the recombinant polyhydroxyalkanoate monomer synthase in the host cell so as to generate a polyhydroxyalkanoate monomer.
23 . A recombinant vector comprising one or more modules of a polyketide synthase wherein at least one module is from Streptomyces venezuelae.
24 . The method of claim 22 wherein the first module encodes a fatty acid synthase.
25 . A method of providing a polyhydroxyalkanoate monomer, comprising:
(a) introducing into a host cell a DNA molecule encoding a fusion polypeptide, wherein the DNA molecule comprises a first DNA segment operably linked to a promoter functional in the host cell and a second DNA segment, wherein at least one DNA segment is derived from the pikA gene cluster of Streptomyces venezuelae; and (b) expressing the DNA in the host cell so as to generate the fusion polypeptide.
26 . The host cell of claim 16 the native genome of which does not comprise an intact macrolide biosynthetic gene cluster encoding methymycin, pikomycin, neomethymycin, or narbomycin.Join the waitlist — get patent alerts
Track US2002164742A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.